MAPT and Parkinson disease: In the present study, we have used A53Tα-syn conditionally transgenic mice to construct PD models with different expression levels of tau, all of which had developed selective loss of SNC dopaminergic neurons and severe motor coordination and balance disorders, as described previously (Jiao et al., 2020).